2019 Hand, Foot and Mouth Disease Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets

February 2019 | 39 pages | ID: 2C2231A92FDEN
VPAResearch

Abstracts

The ongoing clinical trial research report- “2019 Hand, Foot and Mouth Disease Ongoing Clinical Trials Study” analyzes the current scenario of all active Hand, Foot and Mouth Disease trials across the world. The report presents top level analysis of global Hand, Foot and Mouth Disease clinical trials across countries, companies and universities. It is designed to provide clear understanding into the Hand, Foot and Mouth Disease trials landscape to assist users for effective long term strategy formulation to beat competition.

The report covers a key snapshot of ongoing trial count, average enrollment per trial across countries.

It also segments the Hand, Foot and Mouth Disease clinical trials by-

• Region (Asia Pacific, Europe, Middle East Africa and Americas)
• Countries
• Trial Phase
• Current Trial Status (Recruiting, Active, Planned, Active but Completed Recruiting, Not Yet Recruiting etc)
• Type of the trial (Interventional, Observational)
• Sponsor Type (Companies, Universities, Government Bodies etc)
• Enrollment across types, sponsor types, geographies, current status and phases

The report also identifies the potential drug candidates under development for treatment of Hand, Foot and Mouth Disease on the basis of intervention type ongoing Hand, Foot and Mouth Disease trials.

The research work is prepared through extensive and continuous research on Hand, Foot and Mouth Disease trials from over 150 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

REPORT SCOPE AND COVERAGE:

• All major ongoing trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Hand, Foot and Mouth Disease patients are identified
• The report includes panorama of ongoing Hand, Foot and Mouth Disease clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Hand, Foot and Mouth Disease clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Hand, Foot and Mouth Disease Ongoing Clinical Trials Overview, 2019
2.2 Premium Insights into Ongoing Clinical Trials
  2.2.1 Ongoing Hand, Foot and Mouth Disease Clinical Trials by Region
  2.2.2 Average Enrollment of Hand, Foot and Mouth Disease Clinical Trials
  2.2.3 Companies participating in Ongoing Trials
  2.2.4 Drugs under Study for Hand, Foot and Mouth Disease Treatment, 2019

3. REGION WISE HAND, FOOT AND MOUTH DISEASE CLINICAL TRIALS

3.1 Asia Pacific Hand, Foot and Mouth Disease Clinical Trials by Country
3.2 Europe Hand, Foot and Mouth Disease Clinical Trials by Country
3.3 North America Hand, Foot and Mouth Disease Clinical Trials by Country
3.4 Middle East and Africa Hand, Foot and Mouth Disease Clinical Trials by Country
3.5 South and Central America Hand, Foot and Mouth Disease Clinical Trials by Country

4. HAND, FOOT AND MOUTH DISEASE CLINICAL TRIAL TRENDS

4.1 Start Year wise Ongoing Hand, Foot and Mouth Disease Clinical Trials
4.2 Phase wise Ongoing Hand, Foot and Mouth Disease Clinical Trials
4.3 Trial Status wise Ongoing Hand, Foot and Mouth Disease Clinical Trials
4.4 Trial Type wise Ongoing Hand, Foot and Mouth Disease Clinical Trials

5. HAND, FOOT AND MOUTH DISEASE AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Hand, Foot and Mouth Disease Trials by Year
5.2 Average Enrollment in Hand, Foot and Mouth Disease Trials by Phase
5.3 Average Enrollment in Hand, Foot and Mouth Disease Trials by Status
5.4 Average Enrollment in Hand, Foot and Mouth Disease Trials by Type of Trial

6. COMPANIES PARTICIPATING IN ONGOING HAND, FOOT AND MOUTH DISEASE CLINICAL TRIALS

6.1 Ongoing Hand, Foot and Mouth Disease Trials by Sponsor Type
6.2 Hand, Foot and Mouth Disease Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Ongoing Hand, Foot and Mouth Disease Trials- Phase
7.2 Ongoing Hand, Foot and Mouth Disease Trials- Phase
7.3 Ongoing Hand, Foot and Mouth Disease Trials- Phase
7.4 Ongoing Hand, Foot and Mouth Disease Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Hand, Foot and Mouth Disease Ongoing Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Ongoing Hand, Foot and Mouth Disease Clinical Trials and Enrolment
Figure 5: Europe – Country wise Ongoing Hand, Foot and Mouth Disease Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Ongoing Hand, Foot and Mouth Disease Clinical Trials and Enrolment
Figure 7: North America – Country wise Ongoing Hand, Foot and Mouth Disease Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Ongoing Hand, Foot and Mouth Disease Clinical Trials and Enrolment
Figure 9: Hand, Foot and Mouth Disease Ongoing Clinical Trials by Phase
Figure 10: Hand, Foot and Mouth Disease Ongoing Clinical Trials by Trial Status
Figure 11: Hand, Foot and Mouth Disease Ongoing Clinical Trials by Type
Figure 12: Hand, Foot and Mouth Disease Ongoing Clinical Trials by Sponsor Type
Figure 13: Hand, Foot and Mouth Disease Ongoing Clinical Trials by Leading Sponsors
Figure 14: Hand, Foot and Mouth Disease Average Enrollment by Phase
Figure 15: Hand, Foot and Mouth Disease Average Enrollment by Trial Status
Figure 16: Hand, Foot and Mouth Disease Average Enrollment by Type
Figure 17: Hand, Foot and Mouth Disease- Average Enrolment by Type of Sponsors
Figure 18: Hand, Foot and Mouth Disease- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Hand, Foot and Mouth Disease Ongoing Clinical Trials Snapshot- 2019
Table 2: Ongoing Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Ongoing Hand, Foot and Mouth Disease Clinical Trials and Enrolment
Table 5: Europe – Country wise Ongoing Hand, Foot and Mouth Disease Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Ongoing Hand, Foot and Mouth Disease Clinical Trials and Enrolment
Table 7: North America – Country wise Ongoing Hand, Foot and Mouth Disease Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Ongoing Hand, Foot and Mouth Disease Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Hand, Foot and Mouth Disease Average Enrollment by Phase
Table 15: Hand, Foot and Mouth Disease Average Enrollment by Trial Status
Table 16: Hand, Foot and Mouth Disease Average Enrollment by Type
Table 17: Hand, Foot and Mouth Disease- Average Enrolment by Type of Sponsors
Table 18: Hand, Foot and Mouth Disease- Enrolment by Leading Sponsors